Rybelsus (semaglutide), first oral GLP-1 treatment for type 2 diabetes
The U.S. Food and Drug Administration has approved Rybelsus (semaglutide) oral…
Victoza, liraglutide, new treatment for children with type 2 diabetes
EMA’s human medicines committee has recommended granting an extension of…